Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ECULIZUMAB vs EFAVIRENZ: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ECULIZUMAB vs EFAVIRENZ: Safety Overview

Metric ECULIZUMAB EFAVIRENZ
Total FAERS Reports 44,190 7,893
Deaths Reported 4,626 962
Death Rate 10.5% 12.2%
Hospitalizations 12,421 1,528
Average Patient Age 42.6 yrs 40.7 yrs
% Female Patients 59.5% 37.7%
FDA Approval Date N/A Apr 27, 2018
Manufacturer Alexion Pharmaceuticals Inc. Camber Pharmaceuticals, Inc.
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued